: From Therapeutic Uses to Micropropagation and Beyond.

The development of a protocol for the large-scale production of and its variants with little to no somaclonal variation or disease for pharmaceutical and for other industrial use has been an emerging area of research. A limited number of protocols have been developed around the world, obtained through a detailed literature search using web-based database searches, e.g.